EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Poison exons: tuning RNA splicing for targeted gene regulation

Christopher R Neil, Cassandra Schaening-Burgos, Maria S Alexis, Dominic J Reynolds, Peter G Smith, Michael W Seiler, Frédéric H Vaillancourt, Anant A Agrawal

Trends in Pharmacological Sciences · 2025-03 · 46 (3) · 264-278

DOI: 10.1016/j.tips.2025.01.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2025-03. Verfasst von Christopher R Neil und 7 weiteren Autor:innen. Beteiligte Einrichtung: Remix Therapeutics, Watertown, MA, USA. Hauptthemen laut MEDLINE: Exons, RNA Splicing, Alternative Splicing, Gene Expression Regulation. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poison exons (PEs) are a class of alternatively spliced exons whose inclusion targets mRNA transcripts for degradation via the nonsense-mediated decay (NMD) pathway. Although a role for NMD as an essential mRNA quality control pathway has long been appreciated, recent advances in RNA sequencing (RNA-seq) strategies and analyses have revealed that its coupling to RNA splicing is broadly used to regulate mRNA stability and abundance. Regulation of PE splicing affects patterns of targeted degradation across the transcriptome and influences gene expression in both healthy and disease states. Importantly, PEs represent a novel therapeutic opportunity to modulate the expression of disease-relevant genes with sequence-specific resolution. We review the emergence of PE splicing in endogenous gene regulation, its misregulation in disease, and the ways in which it can be leveraged for therapeutic benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExonsRNA SplicingAlternative SplicingGene Expression RegulationHumansAnimalsNonsense Mediated mRNA DecayRNA, Messenger

Stichwörter der Autor:innen

RNA processingRNA-targeted therapeuticsnonsense-mediated decaypoison exonssplicing modulators

Substanzen

RNA, Messenger

Autor:innen und Institutionen

  • Remix Therapeutics, Watertown, MA, USA.
  • Remix Therapeutics, Watertown, MA, USA. Electronic address: aagrawal@remixtx.com.

Zitieren

APA

Neil, C. R., Schaening-Burgos, C., Alexis, M. S., Reynolds, D. J., Smith, P. G., Seiler, M. W., Vaillancourt, F. H., & Agrawal, A. A. (2025). Poison exons: tuning RNA splicing for targeted gene regulation. Trends in Pharmacological Sciences, 46(3), 264-278. https://doi.org/10.1016/j.tips.2025.01.002

Vancouver

Neil CR, Schaening-Burgos C, Alexis MS, Reynolds DJ, Smith PG, Seiler MW, et al. Poison exons: tuning RNA splicing for targeted gene regulation. Trends in Pharmacological Sciences. 2025;46(3):264-278. doi:10.1016/j.tips.2025.01.002

BibTeX
@article{Neil2025,
  author = {Neil, Christopher R and Schaening-Burgos, Cassandra and Alexis, Maria S and Reynolds, Dominic J and Smith, Peter G and Seiler, Michael W and Vaillancourt, Frédéric H and Agrawal, Anant A},
  title = {Poison exons: tuning RNA splicing for targeted gene regulation},
  journal = {Trends in Pharmacological Sciences},
  year = {2025},
  volume = {46},
  number = {3},
  pages = {264--278},
  doi = {10.1016/j.tips.2025.01.002}
}
Kostenlos starten →